top.png

RESOURCES

What Is Antimicrobial Resistance (AMR)?

Antimicrobial resistance is a natural process that occurs when bacteria, viruses, fungi and parasites evolve so that existing medications used to treat related infections no longer work. As a result the germs are not killed and continue to grow.

Some types of bacteria and fungi have become resistant to a lot of different antimicrobial treatments.

 

These so-called “superbugs” can continue to grow even when multiple medicines are used to try and treat them.

WHY HAS THIS HAPPENED?

 

Many of the antimicrobial treatments we use today were developed decades ago. As a result, patients require repeated courses of different antibiotics to fight infections that used to be easily cured with one treatment course of a medicine. Additionally, often times patients do not take all of the pills prescribed to them or follow appropriate usage of the medicine. Unfortunately, this can all make the resistance worse. In some cases, antibiotics don’t work at all.

 

As antimicrobial resistance becomes more common, more of us could be prone to infections that aren’t treatable by any antibiotics. In many cases, the infections may even be deadly.

THIS IS NOT A FUTURE PROBLEM. IT IS HAPPENING NOW.

people die

as a result.

and more than

According to the CDC, more than

2.8 million

infections resistant to antibiotics occur in the U.S. each year.

35,000

AMR is a threat to all of us, especially those with chronic conditions. Without effective antibiotics and antifungals, we don’t just lose treatments for serious infections, but we also face significantly increased risks from many common medical services that rely upon the effective prevention and treatment of infections. Those services include complex care like organ transplants, invasive surgeries, or cancer treatment, but can also affect procedures like c-sections, joint replacements, and dialysis.

Group 60.png

We need to encourage more development of new treatments to combat antimicrobial resistant infections.

After decades of helping to lower the mortality rate from pneumonia, tuberculosis and other types of infection, the medicines we rely on now face the growing threat of antimicrobial resistance (AMR). Antimicrobial resistant superbugs are emerging, mutating, and spreading
globally in ways that threaten the ability to treat common infectious diseases, and can result in prolonged illness, disability, and death. The cost of health care for patients with resistant infections is higher than care for patientswith non-resistant infections due to longer duration  of illness, additional tests and more intensive care demands. AMR does not discriminate; it quite literally compromises the future of modern medicine.

We are living amidst a current example of this with COVID-19 and superimposed bacterial pneumonia.

Additional Resources

What is Antimicrobial Resistance - Explainer Video

Watch it

Partnership to Fight Infectious Disease

Webinar Deck

PFID Polling Overview

Download it

PFID Webinar

Watch it

What Are the Real-Life Consequences of Antimicrobial Resistance (AMR)?

bottom.png

About PFID

Partnership to Fight Infectious Disease is a group  of patients, providers, community organizations, business and labor groups, and health  policy  experts working to advance awareness and  action on antimicrobial resistance

tw.png
in.png
Connect with PFID

© Copyright 2020. Partnership to Fight Infectious Disease